Literature DB >> 7577653

Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred.

G Turner1, J Fletcher, J Elber, Y Yanagawa, V Davé, A Yoshida.   

Abstract

The X-chromosome-linked phosphoglycerate kinase (PGK) deficiency associated with severe chronic and acute haemolytic anaemia and mental disorders was first described in a large Chinese kindred in 1969. The molecular abnormality of this original variant remained to be identified. The red cell PGK activity was only about 5%, but the activity of the patients' lymphoblastoid cells was about 15% of normal. The PGK mRNA content of the patients' lymphoblastoid cells were normal. Analysis of the patients' mRNA showed the existence of a nucleotide transversion A-->T at position 491 (counting from adenine of the initiation codon). The mutation should cause an amino acid substitution Asp-->Val at position 163 of the enzyme. The replacement of the acidic aspartic acid by a hydrophobic valine is expected to induce drastic structural instability resulting in severe enzyme deficiency in the patients' tissues. The genotypes of two affected males, their mothers and 22 females of the family were identified by the PCR-mediated method using their genomic DNA samples. 13/24 females examined were found to be variant heterozygous. In this large family, affected males over three generations have died at a pre-adult age. Post- and pre-natal genotyping of the family members may prevent future problems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577653     DOI: 10.1111/j.1365-2141.1995.tb05245.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria.

Authors:  Shigeto Matsumaru; Hirokazu Oguni; Hiromi Ogura; Keiko Shimojima; Satoru Nagata; Hitoshi Kanno; Toshiyuki Yamamoto
Journal:  Intractable Rare Dis Res       Date:  2017-05

2.  A negative waveform in the scotopic response in a patient with phosphoglycerate kinase deficiency: a visual electrophysiology report.

Authors:  Safinaz Mohd Khialdin; John Grigg; Neil Rowe; Stephanie Crofts; Meredith Wilson; Christopher Troedson
Journal:  Doc Ophthalmol       Date:  2015-09-22       Impact factor: 2.379

3.  Myopathy and parkinsonism in phosphoglycerate kinase deficiency.

Authors:  Evangelia Sotiriou; Paul Greene; Sindu Krishna; Michio Hirano; Salvatore DiMauro
Journal:  Muscle Nerve       Date:  2010-05       Impact factor: 3.217

4.  Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency.

Authors:  Laurent R Chiarelli; Simone M Morera; Paola Bianchi; Elisa Fermo; Alberto Zanella; Alessandro Galizzi; Giovanna Valentini
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

5.  Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1.

Authors:  Shiwen Wang; Bowen Jiang; Tengfei Zhang; Lixia Liu; Yi Wang; Yiping Wang; Xiufei Chen; Huaipeng Lin; Lisha Zhou; Yukun Xia; Leilei Chen; Chen Yang; Yue Xiong; Dan Ye; Kun-Liang Guan
Journal:  PLoS Biol       Date:  2015-09-10       Impact factor: 8.029

6.  Protein Stability, Folding and Misfolding in Human PGK1 Deficiency.

Authors:  Giovanna Valentini; Maristella Maggi; Angel L Pey
Journal:  Biomolecules       Date:  2013-12-18

7.  A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population.

Authors:  Virginia Garcia-Solaesa; Pablo Serrano-Lorenzo; Maria Antonia Ramos-Arroyo; Alberto Blázquez; Inmaculada Pagola-Lorz; Mercè Artigas-López; Joaquín Arenas; Miguel A Martín; Ivonne Jericó-Pascual
Journal:  Genes (Basel)       Date:  2019-10-10       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.